echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > Front Immunol: Clinical features and T cell immune characteristics of postpartum hepatitis outbreaks in pregnant women with HBeAg positive chronic HBV infection

    Front Immunol: Clinical features and T cell immune characteristics of postpartum hepatitis outbreaks in pregnant women with HBeAg positive chronic HBV infection

    • Last Update: 2022-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Background: Mother-to-child transmission was previously the main route of transmission of hepatitis B virus (HBV) infection in China, accounting for approximately 40% of chronic infectio.


    Background: Mother-to-child transmission was previously the main route of transmission of hepatitis B virus (HBV) infection in China, accounting for approximately 40% of chronic infectio.


    Objective: To this end, to analyze the clinical characteristics of patients with or without postpartum hepatitis outbreaks, and to preliminarily explore the differences in immune functi.


    METHODS: Women with CHB infection who were pregnant (below 8 weeks' gestation) and who were planning to become pregnant who were treated at Beijing You'an Hospital Affiliated to Capital Medical University from July 2017 to July 2018 were selected, and agreed to undergo NA intervention in the third trimester of pregnancy to prevent maternal Infant transmissi.


    Results: A total of 15 patients with postpartum hepatitis were included in the first group, and 10 matched patients were selected as the control group in the second gro.


    Figure 1 | Clinical characteristics between the two grou.


    Figure 1 | Clinical characteristics between the two grou.


    Figure 2 | Gating strategies for CD8+ T cell populations and other marke.


    Figure 2 | Gating strategies for CD8+ T cell populations and other marke.


    Figure 3 | Changes in CD38 and HLA-DR-expressing CD8+ T cells and phenotypic subse.


    Figure 3 | Changes in CD38 and HLA-DR-expressing CD8+ T cells and phenotypic subse.


    Figure 4 | Changes in CD107a, GranB and perforin expressing CD8+ T cel.


    Figure 4 | Changes in CD107a, GranB and perforin expressing CD8+ T cel.


    Figure 5 | | Changes in IFN-g and IL-2 expression in CD8+ T cel.


    Figure 5 | | Changes in IFN-g and IL-2 expression in CD8+ T cel.


    Conclusion: The changes in the immune characteristics of CD8+ T cells may play a role in the immune tolerance of hepatitis patients after bankruptcy, and the related indicators of activation and killing functions may help to indicate that there may be postpartum hepatitis patien.


    Original source: Song A, Liu Y, Cao Z, et .

    Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infecti.

    Front Immunol 2022;13 Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infecti.

    Leave a Comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.